Influence of methylation on the antibacterial properties of triclosan in Pasteurella multocida and Pseudomonas aeruginosa variant strains

Journal of Hospital Infection

Volumn 77, Issue 2, 2011, Pages 129-133

  Clayborn, A B ^a,b   Toofan, S N ^b   Champlin, F R ^b  

^a NORTHEASTERN STATE UNIVERSITY   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Bacterial cell envelope; Biocide resistance; Methyl triclosan; Pasteurella multocida; Pseudomonas aeruginosa; Triclosan

Indexed keywords

METHYL TRICLOSAN; TRICLOSAN; UNCLASSIFIED DRUG;

AGAR DIFFUSION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BIOASSAY; CONTROLLED STUDY; METHYLATION; NONHUMAN; PASTEURELLA MULTOCIDA; PSEUDOMONAS AERUGINOSA;

ANTI-INFECTIVE AGENTS, LOCAL; DRUG RESISTANCE, BACTERIAL; HUMANS; METHYLATION; METHYLTRANSFERASES; PASTEURELLA MULTOCIDA; PSEUDOMONAS AERUGINOSA; TRICLOSAN;

EID: 78951482794     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.09.021     Document Type: Article

References (31)

1. McMurry L.M., Oethinger M., Levy S.B. Triclosan targets lipid synthesis. Nature 1998, 394:531-532.
2. Champlin F.R., Ellison M.L., Bullard J.W., Conrad R.S. Effect of outer membrane permeabilisation on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa. Int J Antimicrob Agents 2005, 26:159-164.
3. Ellison M.L., Roberts A.L., Champlin F.R. Susceptibility of compound 48/80-sensitized Pseudomonas aeruginosa to the hydrophobic biocide triclosan. FEMS Microbiol Lett 2007, 269:295-300.
4. Ellison M.L., Champlin F.R. Outer membrane permeability for nonpolar antimicrobial agents underlies extreme susceptibility of Pasteurella multocida to the hydrophobic biocide triclosan. Vet Microbiol 2007, 124:310-318.
5. Hoang T.T., Schweizer H.P. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. J Bacteriol 1999, 181:5489-5497.
6. Heath R.J., Rock C.O. A triclosan-resistant bacterial enzyme. Nature 2000, 406:145-146.
7. Mima T., Joshi S., Gomez-Escalada M., Schweizer H.P. Identification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginosa requiring two membrane fusion proteins. J Bacteriol 2007, 189:7600-7609.
8. Hart M.E., Champlin F.R. Susceptibility to hydrophobic molecules and phospholipid composition in Pasteurella multocida and Actinobacillus lignieresii. Antimicrob Agents Chemother 1988, 32:1354-1359.
9. Pereira L.J., Lee G.M., Wade K.J. An evaluation of five protocols for surgical handwashing in relation to skin condition and microbial counts. J Hosp Infect 1997, 36:49-65.
10. Zafar A.B., Butler R.C., Reese D.J., Gaydos L.A., Mennonna P.A. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 1995, 23:200-208.
11. Mixon GC, Inventor. Antimicrobial gloves and a method of manufacture thereof. United States patent US 5906823. 1999 May 25.
12. Edmiston C.E., Seabrook G.R., Goheen M.P., et al. Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination?. J Am Coll Surg 2006, 203:481-489.
13. Fleck T., Moidl R., Blacky A., et al. Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg 2007, 84:232-236.
14. Microtek Medical, Inc. Columbus (MS). Isodrape surgical film drapes featuring Microban. Manufacturer's brochure. 2002. Literature No.: LIT013183-2500.
15. Jones R.D., Jampani H.B., Newman J.L., Lee A.S. Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control 2000, 28:184-196.
16. Allmyr M., Adolfsson-Erici M., McLachlan M.S., Sandborgh-Englund G. Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci Tot Environ 2006, 372:87-93.
17. Líndström A., Buerge I.J., Poiger T., Bergqvist P.-A., Müller M.D., Buser H.-R. Occurrence and environmental behavior of the bactericide triclosan and its methyl derivative in surface waters and in wastewater. Environ Sci Technol 2002, 36:2322-2329.
18. Bester K. Fate of triclosan and triclosan-methyl in sewage treatment plants and surface waters. Arch Environ Contam Toxicol 2005, 49:9-17.
19. DeLorenzo M.E., Keller J.M., Arthur C.D., et al. Toxicity of the antimicrobial compound triclosan and formation of the metabolite methyl-triclosan in estuarine systems. Environ Toxicol 2008, 23:224-232.
20. Gómez M.J., Agüera A., Mezcua M., Hurtado J., Mochilí F., Fernández-Alba A.R. Simultaneous analysis of neutral and acidic pharmaceuticals as well as related compounds by gas chromatography-tandem mass spectrometry in wastewater. Talanta 2007, 73:314-320.
21. Nikaido H., Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev 1985, 49:1-32.
22. Zimmermann W. Penetration through the gram-negative cell wall: a co-determinant of the efficacy of beta-lactam antibiotics. Int J Clin Pharmacol Biopharm 1979, 17:131-134.
23. Champlin F.R., Patterson C.E., Austin F.W., Ryals P.E. Derivation of extracellular polysaccharide-deficient variants from a serotype A strain of Pasteurella multocida. Curr Microbiol 1999, 38:268-272.
24. Darnell K.R., Hart M.E., Champlin F.R. Variability of cell surface hydrophobicity among Pasteurella multocida somatic serotype and Actinobacillus lignieresii strains. J Clin Microbiol 1987, 25:67-71.
25. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev 1992, 56:395-411.
26. Meade M.J., Waddell R.L., Callahan T.M. Soil bacteria Pseudomonas putida and Alcaligenes xylosoxidans subsp. dentrificans inactivate triclosan in liquid and solid substrates. FEMS Microbiol Lett 2001, 204:45-48.
27. Leiker T.J., Abney S.R., Goodbred S.L., Rosen M.R. Identification of methyl triclosan and halogenated analogues in male common carp (Cyprinus carpio) from Las Vegas Bay and semipermeable membrane devices from Las Vegas Wash, Nevada. Sci Tot Environ 2009, 407:2102-2114.
28. Farré M., Asperger D., Kantiani L., González S., Petrovic M., Barceló D. Assessment of the acute toxicity of triclosan and methyl triclosan in wastewater based on the bioluminescence inhibition of Vibrio fischeri. Anal Bioanal Chem 2008, 390:1999-2007.
29. Balmer M.E., Poiger T., Droz C., et al. Occurrence of methyl triclosan, a transformation product of the bactericide triclosan, in fish from various lakes in Switzerland. Environ Sci Technol 2004, 38:390-395.
30. Heath R.J., Rubin J.R., Holland D.R., Zhang E., Snow M.E., Rock C.O. Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chem 1999, 274:11110-11114.
31. Braoudaki M., Hilton A.C. Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J Clin Microbiol 2004, 42:73-78.